Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
Triple-negative breast cancer (TNBC) cells do not express estrogen receptors, progesterone receptors, or human epidermal growth factor receptor 2. Currently, apart from poly ADP-ribose polymerase inhibitors, there are few effective therapeutic options for this type of cancer. Here, we present compre...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-06-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5500377?pdf=render |